프로그램
| Time | Title | Chairperson/Speaker |
|---|---|---|
| 08:55-09:00 | Registration | |
| 09:00-09:05 | Opening Remarks | Yun Sil Chang (Director of Cell and Gene Therapy Institute, Samsung Medical Center) |
| 09:05-09:10 | Welcome Address | Kyu-Sung Lee (Director, Research Institute for Future Medicine, Samsung Medical Center) |
| 09:10-09:15 | Congratulatory Address | Seung Woo park (President of Samsung Medical Center) |
| Session I. Perspective: Advanced Technology of Cell · Gene Therapy to Clinical Progress | ||
| Chair : Dong-Ik Kim (Samsung Medical Center, Sungkyunkwan University School of Medicine) Jeehun Lee (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
| 09:15-09:30 | Gene therapy of SMA: its implication | Jeehun Lee (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
| 09:30-09:45 | Development of gene therapy for inherited retinal degeneration | Sang Jin Kim (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
| 09:45-10:00 | EN001, an early-passage mesenchymal stem cell, is safe and effective in patients with Charcot-Marie-Tooth disease type 1A | Byung-Ok Choi (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
| 10:00-10:15 | Homogeneity of human chemically derived hepatic progenitors by sequential stem cell specific monoclonal antibody sorting diminishes the fibrotic features of stem cells. | Dongho Choi (Hanyang University College of Medicine) |
| 10:15-10:30 | Discussion | |
| Session II. Translational & Clinical Research of Cell · Gene therapy for Incurable Diseases | ||
| Chair : Il-Hoan Oh (The Catholic University of Korea) Yun Sil Chang (Director of Cell and Gene Therapy Institute, Samsung Medical Center) |
||
| 10:30-11:00 | Hematopoietic Stem Cell Gene Therapy for Treatment of Rare Fatal Diseases | David A. Williams (Harvard Medical School, USA) |
| 11:00-11:05 | Discussion | |
| 11:05-11:35 | Translational Research in Rare Neurological Disorders | Mustafa Sahin (Harvard Medical School, USA) |
| 11:35-11:40 | Discussion | |
| 11:40-12:10 | Novel Genetically corrected Pluripotent cell-derived tissue organoids for Definitive Wound Therapy | Anthony E. Oro (Stanford University, USA) |
| 12:10-12:15 | Discussion | |
| 12:15-13:15 | Lunch | |
| Session III. Perspective: Advanced Technology of Cell Therapy to Clinical Progress | ||
| Chair: Ssang-Goo Cho (Konkuk University & StemEXOne Inc.) Jae Ho Kim (Pusan National University School of Medicine) |
||
| 13:15-13:30 | Application of iPS Cell-derived therapeutics for chronic degenerative diseases | Ji Hyeon Ju (Seoul St. Mary's Hospital, The Catholic University of Korea) |
| 13:30-13:45 | Human pluripotent stem cell-based neurodegenerative disease modeling | Yohan Oh (Department of Biomedical Science, Hanyang University) |
| 13:45-14:00 | Dissecting Human Diseases with Genetics and Pluripotent Stem cells | Kihyun Lee (College of Pharmacy, Ewha Womans University) |
| 14:00-14:15 | Discussion | |
| Session IV. Recent Advances and Future Perspectives-Exosome and Organoid | ||
| Chair : Seung-Yup Ku (Seoul National University College of Medicine ) Oh Young Bang (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
| 14:15-14:30 | In vitro generation and characterization of vascularized multilineage liver organoids & extracellular vesicles derived from hPSCs | Jong-Hoon Kim (Korea University) |
| 14:30-14:45 | Unlocking Exosome Potential: Innovations for Targetability and Productivity | Say-June Kim (Seoul St. Mary's Hospital, The Catholic University of Korea) |
| 14:45-15:00 | Cell-Free Nanotherapy Platform Technologies as Revolutionary Regenerative Immunotherapy | Gi-Hoon Nam (SHIFTBIO INC./Korea University College of Medicine) |
| 15:00-15:15 | Functional Brain Organoid-based Future Precision Medicine | Jong-Chan Park (Department of Biophysics, Sungkyunkwan University) |
| 15:15-15:35 | Discussion | |
| 15:35-15:45 | Break | |
| Session V. Advanced disease modeling using Gene-modified cell therapy I | ||
| Chair : Joon Ho Wang (Samsung Medical Center, Sungkyunkwan University School of Medicine) Keon Hee Yoo (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
| 15:45-16:00 | Gene therapy in inborn error of immunity (immunodeficiency) | Yae-Jean Kim (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
| 16:00-16:15 | Precise Gene Editing in Rare Diseases | Sangsu Bae (Seoul National University College of Medicine) |
| 16:15-16:25 | Discussion | |
| Session VI. Advanced disease modeling using Gene-modified cell therapy II | ||
| Chair : Heechung Kwon(CEO, Gencellmed Inc., Advisor, KSGCT) Hye Ryoun Jang(Samsung Medical Center, Sungkyunkwan University School of Medicine) |
||
| 16:25-16:40 | Rewrting the code: advancing therapies for neurofibromatosis and NUT carcinoma. | Yoon-La Choi (Samsung Medical Center, Sungkyunkwan University School of Medicine) |
| 16:40-16:55 | Mutation deletion strategy using TaRGET gene editing platform | Yong-Sam Kim (GenKOre) |
| 16:55-17:10 | A Framework for Individualized Splice-Switching Oligonucleotide Therapy | Jinkuk Kim (Graduate School of Medical Science and Engineering, KAIST) |
| 17:10-17:25 | Discussion | |
| 17:25- | Adjourn | |